Celldex Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.3M | 37k | 33.99 |
| 2024-06-30 | $1.4M | 37k | 37.01 |
| 2023-12-31 | $955k | 24k | 39.66 |
| 2023-09-30 | $663k | 24k | 27.52 |
| 2023-06-30 | $817k | 24k | 33.93 |
| 2023-03-31 | $854k | 24k | 35.98 |
| 2022-12-31 | $1.1M | 25k | 44.57 |
| 2022-09-30 | $709k | 25k | 28.11 |
| 2022-06-30 | $680k | 25k | 26.96 |
| 2022-03-31 | $859k | 25k | 34.06 |
| 2021-12-31 | $620k | 16k | 38.61 |
| 2021-09-30 | $867k | 16k | 54.00 |
| 2021-06-30 | $485k | 15k | 33.44 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors